OpenAlex
PricingAboutJobs
Log inGet started
Work

The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma

HTML

Year: 2010
Type: article
Study design: Clinical Trial
Source: European Journal of Cancer
DOI: 10.1016/j.ejca.2010.07.033
Authors: Manfred Johannsen, Gianluca Spitaleri, Giuseppe Curigliano, Jan Roigas, Steffen Weikert, Carsten Kempkensteffen, Andreas Roemer, Christian Kloeters, Patrik Rogalla, Gabriele Pecher, Kurt Miller, Alexander Berndt, Hartwig Kosmehl, Eveline Trachsel, Manuela Kaspar, Valeria Lovato, Reinerio González-Iglesias, Leonardo Giovannoni, Hans D. Menssen, Dario Neri, Filippo de Braud
Institutions: Charité – Universitätsmedizin Berlin, European Institute of Oncology, Jena University Hospital, Helios Klinikum Erfurt, Philochem (Switzerland), Philogen (Italy), Bayer (Germany), ETH Zurich, Institute of Pharmaceutical Sciences
Language: English

Topic: Monoclonal and Polyclonal Antibodies Research
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: L19-IL2, immunocytokines, interleukin-2, renal cell carcinoma, metastatic renal cell carcinoma, solid tumors, pharmacokinetics, safety and tolerability, recommended phase 2 dose, tumor targeting
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2092941122
FWCI: 6.426
Cites: 32
Cited by: 195
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms